Welcome to the Kids' Library!

Brand-name prescription drug pricing lack of therapeutically equivalent drugs and limited competitio

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

CBO's simulation model of new drug development

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcom

United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2003. 2003

How health care reform affects pharmaceutical research and development

Cook, Anna (Anna E.)
Washington, D.C. : Congressional Budget Office, [1994] 1994

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Tra

United States. Congress. Senate. Committee on Finance. Subcommittee on International Trade.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce.

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]- 2019